Fáddáevttohusat
Fáddáevttohusat
- Cancer
- Chemotherapy
- drug therapy 84
- Antineoplastic Agents 78
- Antineoplastic agents 74
- Neoplasms 72
- therapeutic use 45
- Precision Medicine 32
- Treatment 31
- genetics 28
- Personalized medicine 26
- therapy 26
- pharmacology 25
- metabolism 24
- drug effects 20
- methods 20
- Complications 18
- Drugs 18
- Immunotherapy 18
- Pharmacogenetics 17
- Pharmacogenomics 17
- adverse effects 17
- Pharmaceutical Preparations 16
- Genetic aspects 15
- immunology 15
- Breast Neoplasms 13
- Clinical Trials as Topic 13
- Breast 12
- Immunopharmacology 12
- Molecular Targeted Therapy 12
-
1
Role of molecular markers in guiding therapy in cancer
Almmustuhtton 2015Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
2
Key considerations for cancer pharmacotherapy part 2 of 2 /
Almmustuhtton 2017Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
3
Key considerations for cancer pharmacotherapy part 1 of 2 /
Almmustuhtton 2017Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
4
Functional cancer genomics
Almmustuhtton 2015Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
5
Immune checkpoint blockade in CNS tumors
Almmustuhtton 2016Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
6
Cancer treatment paradigms
Almmustuhtton 2018Fáttát: “…Cancer Chemotherapy.…”
Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
7
Role of molecular markers in guiding therapy in cancer
Almmustuhtton 2015Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
8
Role of molecular markers in guiding therapy in cancer
Almmustuhtton 2015Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
9
Soreness and ulcers 5, Biology, diagnosis and management of cancer regimen-related oral mucosal injury, part 1 of 2 /
Almmustuhtton 2017Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
10
Key considerations for cancer pharmacotherapy part 2 of 2 /
Almmustuhtton 2017Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
11
Key considerations for cancer pharmacotherapy part 2 of 2 /
Almmustuhtton 2017Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
12
-
13
Key considerations for cancer pharmacotherapy part 1 of 2 /
Almmustuhtton 2017Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
14
Key considerations for cancer pharmacotherapy part 1 of 2 /
Almmustuhtton 2017Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
15
Functional cancer genomics
Almmustuhtton 2015Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
16
Functional cancer genomics
Almmustuhtton 2015Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
17
Immune checkpoint blockade in CNS tumors
Almmustuhtton 2016Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
18
Immune checkpoint blockade in CNS tumors
Almmustuhtton 2016Fáttát: Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
19
Cancer treatment paradigms
Almmustuhtton 2018Fáttát: “…Cancer Chemotherapy. 93677…”
Viečča ollesdeavstta
Series
Elektrovnnalaš Video -
20
Cancer treatment paradigms
Almmustuhtton 2018Fáttát: “…Cancer Chemotherapy. 93677…”
Viečča ollesdeavstta
Series
Elektrovnnalaš Video